Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer with Dr Ashish Kamat

Episode 29 · November 5th, 2020 · 51 mins 51 secs

About this Episode

Dr Ashish Kamat from the University of Texas MD Anderson Cancer Center in Houston discusses recently published and emerging research on the use of immune checkpoint inhibitors and other novel therapies for patients with urothelial bladder cancer.

CME information and select publications here.